Filter
1555
Text search:
drug
registration
Featured
130
514
Language
Document type
993
207
163
80
65
16
13
10
6
1
1
Countries / Regions
160
57
47
42
39
39
38
37
37
36
34
33
32
31
29
28
25
21
20
19
19
16
16
15
15
14
13
13
9
9
9
7
7
6
6
6
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
810
110
73
44
42
32
18
Toolboxes
174
103
76
73
69
46
40
30
29
27
25
23
16
16
14
13
8
7
7
6
5
4
2
2
1
User manual.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
PMPB/INS-GUIDE/01
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
Standard Operating Procedures for Implementation of TB Activities at HIV/AIDS Service Delivery Sites
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Policy and Manual
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
Human Rights, Minimum Standards and Monitoring at the European and International Levels
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
